Getting to the top of the IPO chart, MEDEZE Group Public Company Limited (MEDEZE), a provider of stem cell analysis, isolation, cultivation, storage, and immune cell potency testing (NK Cells), has become one of the hottest IPO stocks. After setting the IPO price at 9 baht per share, the company quickly received overwhelming demand from investors. Recently, value investing (VI) experts have been flocking to subscribe to MEDEZE's IPO, eager for long-term investment. This highlights MEDEZE's potential for continuous growth. With such strong fundamentals, it’s definitely a stock worth adding to your portfolio! For those who missed the IPO subscription, don’t worry – MEDEZE is scheduled to start trading on the SET on October 15th.
Investor News
03.03.2025
MEDEZE Delivers 2024 Net Profit 338.74 million Baht, up 41.39% Establishes Cell Banking Biotechnology in the Philippines
Read More
23.12.2024
MEDEZE สร้างประวัติศาสตร์ใหม่! ได้รับคัดเลือกเข้าสู่ “FTSE SET Shariah Index”
Read More
19.12.2024
MEDEZE Invests 100 Million Baht to Expand into the Health and Beauty Market with a New Subsidiary “Medeze Hair Renaissance”
Read More
12.12.2024
ตัวเลขคาดการณ์ ปี 2567
Read More
12.12.2024
ผลประกอบการ MEDEZE 9 เดือนแรก ปี 2567
Read More
11.12.2024
MEDEZE Proud to be Included in the FTSE SET Shariah Index Enhancing Investment Appeal and Opening Opportunities for Global Business Expansion
Read More
14.11.2024
MEDEZE Highlights Global Growth in Stem Cell Storage Numbers Affirms Strict Compliance with Legal Regulations in Business Operations
Read More
13.11.2024
MEDEZE Reports 240.47 Million Baht Profit in 9 Months of 2024, Up 30% YOY Expands Partnerships to Boost Revenue, Automated Cultivation Machine Reduces Costs
Read More
04.11.2024
MEDEZE Adheres to the Medical Council’s Stem Cell Regulations Confident in Standardized Storage System, Ready for Use According to Ministry of Public Health Announcement
Read More
10.10.2024
MEDEZE Catches the Eye of VI Experts Subscription Demand Surges
Read More
07.10.2024
MEDEZE in High Demand: IPO Fully Subscribed Confident in Strong Fundamentals, Raising Funds to Expand Profit Base Amid Business Growth Cycle
Read More
09.09.2024
The SEC Approves Filing for MEDEZE Group's IPO of 268 Million Shares to Expand Hair Follicle Cell Business and Robotic Cell Storage System
Read More